Bacterial Vaginosis
Bacterial Vaginosis (BV), also known as vaginal dysbiosis or Vaginal Dysbacteriosis, is a common vaginal infection. Learn about BV diagnosis, clinical documentation, and medical coding including ICD-10 codes and SNOMED CT terms for accurate healthcare records. Find information on BV symptoms, treatment, and prevention. This resource supports healthcare professionals in proper diagnosis and coding of Bacterial Vaginosis.
Imbalance of vaginal bacteria, not an STI.
Thin, grayish-white discharge with a fishy odor. May cause itching or burning.
Primary care, gynecology, sexual health clinics.
ICD-10 Code Families
Complete code families applicable to N76.0
When to use each related code
| Description | When to use |
|---|---|
| Bacterial imbalance in the vagina. | Code for fishy odor, thin discharge, clue cells, elevated pH. Use 'Bacterial Vaginosis' not alternate names. |
| Yeast infection of the vagina. | Code for thick, white discharge, itching, burning. Search 'vulvovaginal candidiasis' for related codes. |
| Inflammation of the vagina. | Code for vaginal irritation, discharge, dyspareunia, often with an infectious cause. |
Best-practice checklist
- ✓Document Amsel criteria results.
- ✓Describe vaginal discharge: color, consistency, odor.
- ✓Record pH of vaginal fluid.
- ✓Note presence/absence of clue cells on microscopy.
- ✓Document Nugent score if performed.
Common pitfalls to avoid
Using unspecified codes like N89.8 (Other specified noninflammatory disorders of vagina) when a more specific code for Bacterial Vaginosis (N76.0) is clinically supported.
Overlooking documentation suggesting BV and failing to code N76.0, impacting quality metrics and reimbursement.
Variability in coding BV (N76.0) based on documentation nuances, leading to compliance issues and inaccurate data reporting.
Best-practice tips
- 01Document vaginal pH >4.5, clue cells for accurate BV coding.
- 02Rule out other STIs/vaginitis for specific diagnosis, improved CDI.
- 03Adhere to CDC treatment guidelines for BV, ensure compliance.
- 04Educate patients on risk factors, recurrence prevention for better outcomes.
- 05Consistent documentation improves BV data tracking, aids public health initiatives.
Step-by-step checklist
- 1
1. Amsel Criteria met? (3/4: thin discharge, pH>4.5, clue cells, whiff test)
- 2
2. Nugent score assessed? (Consider if Amsel unclear)
- 3
3. Other vaginal infections (Candida, Trichomonas) ruled out?
- 4
4. Patient pregnant? (Treatment implications)
- 5
5. Document symptoms, exam findings, and diagnostic method
Ready-to-paste narrative
Patient presents with complaints consistent with bacterial vaginosis (BV). She reports a thin, homogenous, off-white or gray vaginal discharge with a characteristic fishy odor, which she notes is more prominent after intercourse. The patient denies vaginal itching or burning. On speculum examination, a homogenous, milky discharge is noted in the vaginal vault. No erythema or edema of the vaginal walls or cervix is observed. A vaginal pH of >4.5 was measured using a nitrazine test. Microscopic examination of a saline wet mount revealed clue cells, indicative of BV. No trichomonads or yeast were observed. The Amsel criteria were met with positive findings for homogenous vaginal discharge, vaginal pH >4.5, positive whiff test (amine odor upon addition of 10% KOH), and the presence of clue cells on microscopy. Diagnosis of bacterial vaginosis confirmed. Treatment plan includes metronidazole 500mg orally twice daily for seven days. Patient education provided regarding medication administration, potential side effects, and avoidance of alcohol during treatment. Follow-up appointment scheduled in two weeks to assess treatment response and rule out any recurrent bacterial vaginosis. Differential diagnoses considered included trichomoniasis and vulvovaginal candidiasis, which were ruled out based on clinical findings and microscopy. ICD-10 code N89.5 assigned.
Common questions and answers
What are the most effective bacterial vaginosis treatment strategies for recurrent cases in women of reproductive age, considering antibiotic resistance and patient comfort?+
Recurrent bacterial vaginosis (BV) poses a significant challenge due to emerging antibiotic resistance and the impact on patient quality of life. For women of reproductive age, a multifaceted approach is crucial. Initial treatment should follow recommended guidelines, typically involving metronidazole or clindamycin. However, for recurrent BV, extending the duration of treatment or utilizing alternative routes of administration, such as vaginal metronidazole gel, may be considered. Explore how intravaginal boric acid can be implemented as an adjunct or alternative therapy, particularly for those experiencing frequent recurrences. Consider implementing strategies to restore the vaginal microbiota, such as probiotics containing Lactobacillus species, after antibiotic treatment. Patient education on modifiable risk factors, like smoking cessation and avoiding douching, is essential. Learn more about current research on novel therapeutic approaches for recurrent BV, including bacteriophage therapy and immune-modulating agents.
How can I differentiate bacterial vaginosis from other vaginal infections like Trichomoniasis and Vulvovaginal Candidiasis (VVC) in a clinical setting using Amsel's criteria and microscopy?+
Distinguishing bacterial vaginosis (BV) from Trichomoniasis and Vulvovaginal Candidiasis (VVC) requires a combination of clinical presentation and laboratory evaluation. Amsel's criteria are a valuable tool for diagnosing BV in a clinical setting. These criteria include the presence of homogenous, thin, milky discharge; vaginal pH greater than 4.5; a positive whiff test upon addition of 10% potassium hydroxide to vaginal secretions; and the presence of clue cells on microscopy. While clue cells are highly indicative of BV, microscopy also aids in differentiating other infections. Trichomoniasis typically presents with motile trichomonads observed under a microscope, often accompanied by a frothy, yellow-green discharge and vulvar irritation. In contrast, VVC typically presents with thick, white, cottage cheese-like discharge, and microscopy reveals budding yeast and pseudohyphae. Consider implementing a Nugent score analysis for a more quantitative assessment of BV based on the relative proportions of bacterial morphotypes observed under Gram stain microscopy. Explore how molecular diagnostic methods, such as PCR, can provide increased sensitivity and specificity for identifying BV and other vaginal infections.
What are the evidence-based recommendations for bacterial vaginosis screening and treatment during pregnancy to minimize adverse pregnancy outcomes, such as preterm birth?+
Bacterial vaginosis (BV) during pregnancy is associated with increased risk of adverse outcomes, including preterm premature rupture of membranes (PPROM) and preterm birth. Current evidence suggests that universal screening for BV in early pregnancy may not be beneficial for all women. However, screening and treatment are recommended for pregnant individuals with a history of preterm birth or those at high risk for preterm delivery. Treatment typically involves oral or vaginal metronidazole or clindamycin, although clindamycin is generally preferred in the first trimester. Explore how screening and treatment for BV at the time of amniocentesis can reduce infection-related complications. Consider implementing strategies to improve adherence to treatment regimens, including patient counseling on potential side effects and the importance of completing the full course of antibiotics. Learn more about the role of probiotic supplementation during pregnancy and its potential impact on BV recurrence and pregnancy outcomes. Ongoing research investigates the most effective screening and treatment strategies for BV during pregnancy to minimize adverse outcomes and improve maternal and fetal health.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.